Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiopharmaceuticals to image infection and inflammation.

O C Boerman1, H Rennen, W J Oyen

  • 1Department of Nuclear Medicine, University Medical Center Nijmegen, The Netherlands.

Seminars in Nuclear Medicine
|November 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [<sup>68</sup>Ga]Ga-DOTA-E-[c(RGDfK)]<sub>2</sub> PET/CT.

European journal of nuclear medicine and molecular imaging·2020
Same author

PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In.

Molecular pharmaceutics·2014
Same author

Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation.

Molecular imaging and biology·2014
Same author

Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model.

Contrast media & molecular imaging·2014
Same author

Response to comment by Aprile et al.: the EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer.

European journal of nuclear medicine and molecular imaging·2014
Same author

Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score.

Digestive surgery·2014

Radiolabeled leukocytes are effective for infection imaging but difficult to prepare. New radiopharmaceuticals, including 99mTc-labeled agents and 18F-FDG PET, offer advanced options for visualizing infection and inflammation.

Area of Science:

  • Nuclear Medicine
  • Radiopharmacology
  • Diagnostic Imaging

Background:

  • Scintigraphic imaging is crucial for diagnosing infectious and inflammatory diseases.
  • Radiolabeled autologous leukocytes are a standard but labor-intensive method.
  • Handling blood products poses infection risks.

Purpose of the Study:

  • To review established and experimental radiopharmaceuticals for infection and inflammation imaging.
  • To discuss the diagnostic potential of these agents.
  • To highlight advancements in nuclear imaging techniques.

Main Methods:

  • Review of existing literature on radiopharmaceuticals for infection/inflammation.
  • Analysis of radiolabeled leukocytes, 67Ga-citrate, 99mTc-labeled antibodies, peptides, and cytokines.

Related Experiment Videos

  • Inclusion of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for high-resolution imaging.

    • Main Results:

    • Radiolabeled leukocytes accurately visualize infectious/inflammatory foci.
    • Alternative agents like 67Ga-citrate and 99mTc-labeled antibodies are available.
    • New 99mTc-labeled ligands (monoclonal antibodies, peptides, cytokines) are under development.
    • FDG-PET offers high spatial resolution for inflammatory foci.

    Conclusions:

    • Established and novel radiopharmaceuticals offer diverse options for infection and inflammation scintigraphy.
    • Emerging agents aim to improve specificity and differentiate between infection and non-microbial inflammation.
    • Advancements in radiopharmaceutical development and PET imaging enhance diagnostic capabilities.